Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation

Acta Neurologica Scandinavica

Volumn 115, Issue 4, 2007, Pages 271-274

  Ito, H ^a,b   Nakano, S ^b   Kusaka, H ^b  

^a Tokyo West Tokushukai Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Botulinum toxin type A; Hyperlacrimation; Injection dose; Synkinesis

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BELL PALSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FACIAL NERVE INJURY; FACIAL SYNKINESIS; FEMALE; HUMAN; INJECTION SITE BLEEDING; LACRIMATION DISORDER; LOW DRUG DOSE; MALE; PATHOLOGICAL REFLEX; SUBCUTANEOUS HEMORRHAGE; SYNKINESIS; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SYNKINESIS; TEARS; TREATMENT OUTCOME;

EID: 33947410242     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00746.x     Document Type: Article

References (9)

1. HOLDS JB, ALDERSON K, FOGG SG, ANDERSON RL. Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Ophthalmol Vis Sci 1990;31:964-7.
2. MAY M, CROXSON GR, KLEIN SR. Bell's palsy: management of sequelae using EMG rehabilitation, botulinum toxin, and surgery. Am J Otol 1989;10:220-9.
3. ROGGENKAMPER P, LASKAWI R, DAMENZ W, SCHRODER M, NUSSGENS Z. Orbicular synkinesis after facial nerve paralysis: treatment with botulinum toxin. Doc Opthalmol 1994;86:395-402.
4. ARMSTRONG MWJ, MOUNTAIN RE, MURRAY JAM. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol 1996;21:15-20.
5. BOROOJERDI B, FERBERT A, SCHWARZ M, HERATH H, NOTH J. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1998;65:111-4.
6. RIEMANN R, PFENNIGSDORF S, RIEMANN E, NAUMANN M. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland. Ophthalmolology 1999;106:2322-4.
7. KEEGAN DJ, GEERLING G, LEE JP et al. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Opthalmol 2002;86:43-6.
8. KYRMIZAKIS DE, PANGALOS A, PAPADAKIS CE, LOGOTHETIS J, MAROUDIAS NJ, HELIDONIS ES. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes. J Oral Maxillofac Surg 2004;62:840-4.
9. ZAIDI FH, GREGORY-EVANS K, ACHESON JF, FERGUSON V. Familial Bell's palsy in females: a phenotype with a predilection for eyelids and lacrimal gland. Orbit 2005;24:121-4.